Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours

Por Baro, M, de Llobet, L I, Figueras, A, Skvortsova, I, Mesia, R, Balart, J
Publicado em 2014

Pleiotropic Effects of Epithelial Mesenchymal Crosstalk on Head and Neck Cancer: EMT and beyond

Por Steinbichler, T. B., Savic, D., Dejaco, D., Romani, A., Kofler, B., Skvortsova, I. I., Riechelmann, H., Dudas, J.
Publicado no Cancer Microenviron (2019)

Slug Is A Surrogate Marker of Epithelial to Mesenchymal Transition (EMT) in Head and Neck Cancer

Por Steinbichler, T. B., Dudas, J., Ingruber, J., Glueckert, R., Sprung, S., Fleischer, F., Cidlinsky, N., Dejaco, D., Kofler, B., Giotakis, A. I., Skvortsova, I. I., Riechelmann, H.
Publicado no J Clin Med (2020)

Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)

Por Skvortsov, S, Dudás, J, Eichberger, P, Witsch-Baumgartner, M, Loeffler-Ragg, J, Pritz, C, Schartinger, V H, Maier, H, Hall, J, Debbage, P, Riechelmann, H, Lukas, P, Skvortsova, I
Publicado em 2014